LY2090314

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Advanced CancerLeukemiaPancreatic Cancer

Phase 1

A Study of LY2090314 in Patients With Advanced or Metastatic Cancer

CompletedNCT01287520

Eli Lilly and CompanyAdvanced Cancer

Start: 2007-11-30End: 2011-04-30Updated: 2019-02-25

A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

TerminatedNCT01632306

Eli Lilly and CompanyPancreatic Cancer

Start: 2013-03-31End: 2015-06-30Updated: 2019-01-15

Phase 2

A Study in Participants With Acute Leukemia

CompletedNCT01214603

Eli Lilly and CompanyLeukemia

Start: 2010-11-30End: 2012-12-31Updated: 2018-11-19